• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过不对称细胞分裂诱导 CD8 CAR T 细胞的命运。

Fate induction in CD8 CAR T cells through asymmetric cell division.

机构信息

Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Nature. 2024 Sep;633(8030):670-677. doi: 10.1038/s41586-024-07862-7. Epub 2024 Aug 28.

DOI:10.1038/s41586-024-07862-7
PMID:39198645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11410665/
Abstract

Early expansion and long-term persistence predict efficacy of chimeric antigen receptor T cells (CARTs), but mechanisms governing effector versus memory CART differentiation and whether asymmetric cell division induces differential fates in human CARTs remain unclear. Here we show that target-induced proximity labelling enables isolation of first-division proximal-daughter and distal-daughter CD8 CARTs that asymmetrically distribute their surface proteome and transcriptome, resulting in divergent fates. Target-engaged CARs remain on proximal daughters, which inherit a surface proteome resembling activated-undivided CARTs, whereas the endogenous T cell receptor and CD8 enrich on distal daughters, whose surface proteome resembles resting CARTs, correlating with glycolytic and oxidative metabolism, respectively. Despite memory-precursor phenotype and in vivo longevity, distal daughters demonstrate transient potent cytolytic activity similar to proximal daughters, uncovering an effector-like state in distal daughters destined to become memory CARTs. Both partitioning of pre-existing transcripts and changes in RNA velocity contribute to asymmetry of fate-determining factors, resulting in diametrically opposed transcriptional trajectories. Independent of naive, memory or effector surface immunophenotype, proximal-daughter CARTs use core sets of transcription factors known to support proliferation and effector function. Conversely, transcription factors enriched in distal daughters restrain differentiation and promote longevity, evidenced by diminished long-term in vivo persistence and function of distal-daughter CARTs after IKZF1 disruption. These studies establish asymmetric cell division as a framework for understanding mechanisms of CART differentiation and improving therapeutic outcomes.

摘要

早期扩增和长期持续与嵌合抗原受体 T 细胞 (CART) 的疗效相关,但调节效应器与记忆性 CART 分化的机制,以及不对称细胞分裂是否会诱导人 CART 产生不同命运,这些仍不清楚。在这里,我们展示了靶标诱导的邻近标记可用于分离第一次有丝分裂的近端和远端 CD8 CART,这些 CART 不对称地分配其表面蛋白质组和转录组,导致不同的命运。靶标结合的 CAR 仍然存在于近端子细胞上,这些子细胞继承了类似于激活未分裂 CART 的表面蛋白质组,而内源性 T 细胞受体和 CD8 则富集在远端子细胞上,其表面蛋白质组类似于静止的 CART,分别与糖酵解和氧化代谢相关。尽管具有记忆前体表型和体内长期存活能力,但远端子细胞表现出类似于近端子细胞的短暂强大的细胞毒性活性,揭示了注定成为记忆 CART 的远端子细胞中的效应样状态。既有预先存在的转录本的分配,也有 RNA 速度的变化,这两者都有助于命运决定因素的不对称,从而导致完全相反的转录轨迹。不依赖于幼稚、记忆或效应表面免疫表型,近端子细胞使用已知支持增殖和效应功能的核心转录因子集。相反,在远端子细胞中富集的转录因子抑制分化并促进长寿,这表现在 IKZF1 破坏后,远端子细胞的长期体内持久性和功能降低。这些研究确立了不对称细胞分裂作为理解 CART 分化机制和改善治疗效果的框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/e14ca9e6eaaa/41586_2024_7862_Fig16_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/a41dd5e2d274/41586_2024_7862_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/0c1848f051e1/41586_2024_7862_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/3aee64457f31/41586_2024_7862_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/e0bbba712e06/41586_2024_7862_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/492e1fa60443/41586_2024_7862_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/cb9104ee9810/41586_2024_7862_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/17a5faefecf2/41586_2024_7862_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/c94803835d71/41586_2024_7862_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/c7f05bae2158/41586_2024_7862_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/158a79c81a8a/41586_2024_7862_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/632e2a6a2f5d/41586_2024_7862_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/df76029ae8bf/41586_2024_7862_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/21489c3423c8/41586_2024_7862_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/0f362eb4178e/41586_2024_7862_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/f18443086c9e/41586_2024_7862_Fig15_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/e14ca9e6eaaa/41586_2024_7862_Fig16_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/a41dd5e2d274/41586_2024_7862_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/0c1848f051e1/41586_2024_7862_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/3aee64457f31/41586_2024_7862_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/e0bbba712e06/41586_2024_7862_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/492e1fa60443/41586_2024_7862_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/cb9104ee9810/41586_2024_7862_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/17a5faefecf2/41586_2024_7862_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/c94803835d71/41586_2024_7862_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/c7f05bae2158/41586_2024_7862_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/158a79c81a8a/41586_2024_7862_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/632e2a6a2f5d/41586_2024_7862_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/df76029ae8bf/41586_2024_7862_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/21489c3423c8/41586_2024_7862_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/0f362eb4178e/41586_2024_7862_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/f18443086c9e/41586_2024_7862_Fig15_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b29/11410665/e14ca9e6eaaa/41586_2024_7862_Fig16_ESM.jpg

相似文献

1
Fate induction in CD8 CAR T cells through asymmetric cell division.通过不对称细胞分裂诱导 CD8 CAR T 细胞的命运。
Nature. 2024 Sep;633(8030):670-677. doi: 10.1038/s41586-024-07862-7. Epub 2024 Aug 28.
2
Targeted localization of the mother centrosome in CD8 T cells undergoing asymmetric cell division promotes memory formation.在经历不对称细胞分裂的CD8 T细胞中,母中心体的靶向定位促进记忆形成。
Cell Rep. 2025 Jan 28;44(1):115127. doi: 10.1016/j.celrep.2024.115127. Epub 2025 Jan 6.
3
Regulation of Asymmetric Division by Atypical Protein Kinase C Influences Early Specification of CD8(+) T Lymphocyte Fates.非典型蛋白激酶C对不对称分裂的调节影响CD8(+) T淋巴细胞命运的早期特化。
Sci Rep. 2016 Jan 14;6:19182. doi: 10.1038/srep19182.
4
Proteasome activity regulates CD8+ T lymphocyte metabolism and fate specification.蛋白酶体活性调节CD8 + T淋巴细胞的代谢和命运决定。
J Clin Invest. 2017 Oct 2;127(10):3609-3623. doi: 10.1172/JCI90895. Epub 2017 Aug 28.
5
Modulation of asymmetric cell division as a mechanism to boost CD8 T cell memory.作为一种增强 CD8 T 细胞记忆的机制,调节不对称细胞分裂。
Sci Immunol. 2019 Apr 12;4(34). doi: 10.1126/sciimmunol.aav1730.
6
Metabolic maintenance of cell asymmetry following division in activated T lymphocytes.活化T淋巴细胞分裂后细胞不对称性的代谢维持。
Nature. 2016 Apr 21;532(7599):389-93. doi: 10.1038/nature17442. Epub 2016 Apr 11.
7
cBAF complex components and MYC cooperate early in CD8 T cell fate.cBAF 复合物组件和 MYC 在 CD8 T 细胞命运中早期合作。
Nature. 2022 Jul;607(7917):135-141. doi: 10.1038/s41586-022-04849-0. Epub 2022 Jun 22.
8
Regulation of asymmetric division and CD8+ T lymphocyte fate specification by protein kinase Cζ and protein kinase Cλ/ι.蛋白激酶Cζ和蛋白激酶Cλ/ι对不对称分裂及CD8 + T淋巴细胞命运决定的调控
J Immunol. 2015 Mar 1;194(5):2249-59. doi: 10.4049/jimmunol.1401652. Epub 2015 Jan 23.
9
Asymmetric cell division safeguards memory CD8 T cell development.不对称细胞分裂保障记忆 CD8 T 细胞的发育。
Cell Rep. 2023 May 30;42(5):112468. doi: 10.1016/j.celrep.2023.112468. Epub 2023 May 12.
10
Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8(+) T cell differentiation.mTORC1激酶活性在细胞分裂过程中的不对称遗传决定了CD8(+) T细胞的分化。
Nat Immunol. 2016 Jun;17(6):704-11. doi: 10.1038/ni.3438. Epub 2016 Apr 11.

引用本文的文献

1
Dysfunctional mitochondria in ageing T cells: a perspective on mitochondrial quality control mechanisms.衰老T细胞中的线粒体功能障碍:线粒体质量控制机制的视角
EMBO Rep. 2025 Aug 29. doi: 10.1038/s44319-025-00536-z.
2
Central memory T cells with key TCR repertoires and gene expression profiles dominate influenza CD8+ T cell pools across the human lifespan.具有关键TCR库和基因表达谱的中枢记忆T细胞在人类一生中主导着流感特异性CD8+T细胞库。
Proc Natl Acad Sci U S A. 2025 Jul 29;122(30):e2501167122. doi: 10.1073/pnas.2501167122. Epub 2025 Jul 22.
3
Immune regeneration: implications for cancer immunotherapy and beyond.

本文引用的文献

1
Primate gastrulation and early organogenesis at single-cell resolution.灵长类动物原肠胚形成和早期器官发生的单细胞分辨率研究
Nature. 2022 Dec;612(7941):732-738. doi: 10.1038/s41586-022-05526-y. Epub 2022 Dec 14.
2
Optimal CD8 T cell effector function requires costimulation-induced RNA-binding proteins that reprogram the transcript isoform landscape.最佳的 CD8 T 细胞效应功能需要共刺激诱导的 RNA 结合蛋白,这些蛋白可重新编程转录本异构体景观。
Nat Commun. 2022 Jun 20;13(1):3540. doi: 10.1038/s41467-022-31228-0.
3
Localization of a TORC1-eIF4F translation complex during CD8 T cell activation drives divergent cell fate.
免疫再生:对癌症免疫治疗及其他方面的影响。
J Clin Invest. 2025 Jul 1;135(13). doi: 10.1172/JCI192731.
4
From Multi-Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR-T Cell Therapy.从多组学到可视化及其他:在CAR-T细胞疗法中连接微观与宏观见解
Adv Sci (Weinh). 2025 May;12(20):e2501095. doi: 10.1002/advs.202501095. Epub 2025 May 11.
5
Targeting systemic IL-2 to BCMA CAR-T cells.将全身性白细胞介素-2靶向至靶向B细胞成熟抗原的嵌合抗原受体T细胞(BCMA CAR-T细胞)。
Nat Immunol. 2024 Nov;25(11):1988-1990. doi: 10.1038/s41590-024-01993-9.
TORC1-eIF4F 翻译复合物在 CD8 T 细胞激活过程中的定位驱动不同的细胞命运。
Mol Cell. 2022 Jul 7;82(13):2401-2414.e9. doi: 10.1016/j.molcel.2022.04.016. Epub 2022 May 20.
4
Decade-long leukaemia remissions with persistence of CD4 CAR T cells.长达十年的白血病缓解期与 CD4 CAR T 细胞的持续存在。
Nature. 2022 Feb;602(7897):503-509. doi: 10.1038/s41586-021-04390-6. Epub 2022 Feb 2.
5
Comparison and evaluation of statistical error models for scRNA-seq.单细胞RNA测序(scRNA-seq)统计误差模型的比较与评估
Genome Biol. 2022 Jan 18;23(1):27. doi: 10.1186/s13059-021-02584-9.
6
STAT1 maintains naïve CD8 T cell quiescence by suppressing the type I IFN-STAT4-mTORC1 signaling axis.信号转导和转录激活因子1(STAT1)通过抑制I型干扰素-信号转导和转录激活因子4-雷帕霉素复合物1(IFN-STAT4-mTORC1)信号轴来维持初始CD8 T细胞的静止状态。
Sci Adv. 2021 Sep 3;7(36):eabg8764. doi: 10.1126/sciadv.abg8764. Epub 2021 Sep 1.
7
Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering.靶向递送 CRISPR-Cas9 和转基因可实现复杂免疫细胞工程。
Cell Rep. 2021 Jun 1;35(9):109207. doi: 10.1016/j.celrep.2021.109207.
8
Integrated analysis of multimodal single-cell data.多模态单细胞数据的综合分析。
Cell. 2021 Jun 24;184(13):3573-3587.e29. doi: 10.1016/j.cell.2021.04.048. Epub 2021 May 31.
9
Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation.抑制 CDK4/6 促进 CD8+T 细胞记忆形成。
Cancer Discov. 2021 Oct;11(10):2564-2581. doi: 10.1158/2159-8290.CD-20-1540. Epub 2021 May 3.
10
In vivo CD8 T cell CRISPR screening reveals control by Fli1 in infection and cancer.体内 CD8 T 细胞 CRISPR 筛选揭示了 Fli1 在感染和癌症中的控制作用。
Cell. 2021 Mar 4;184(5):1262-1280.e22. doi: 10.1016/j.cell.2021.02.019. Epub 2021 Feb 25.